Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHollywood Bwl Regulatory News (BOWL)

Share Price Information for Hollywood Bwl (BOWL)

Share Price is delayed by 15 minutes
Get Live Data
277.00    2.50 (0.91%)
Bid:
274.50
Ask:
275.50
Spread: 1.00 (0.364%)
Market Cap: £464.37m
BOWL Live PriceLast checked at - London Stock Exchange

Intraday Hollywood Bwl Share Chart

Share Buyback Programme

Today 07:00

RNS Number : 4579K
Hollywood Bowl Group plc
01 July 2026
 

1 July 2026

 

 

Hollywood Bowl Group plc

("Hollywood Bowl", the "Company" or the "Group")

 

Share Buyback Programme

 

Further to the Company's half year announcement on 27 May 2026, Hollywood Bowl announces today that it has entered into non-discretionary agreements with Investec and Berenberg to purchase, in aggregate, up to £5 million (excluding any associated costs and stamp duty) of the Company's Ordinary Shares of 1 pence each (the "Shares") and to make trading decisions under the Share Buyback independently of the Company in accordance with certain pre-set parameters. The Share Buyback Programme will commence today and end no later than 30 September 2026. 

The Share Buyback Programme reflects the Group's highly cash generative business model and strong balance sheet. In line with Group's capital allocation policy, the Board believes that a share buyback is an attractive way in which to return excess capital to shareholders while also continuing to invest in growing the business.

The purpose of the Share Buyback Programme is to reduce the share capital of the Company. As such, the Company will cancel any shares purchased. 

This arrangement is in accordance with Chapter 9 of the UK Listing Rules and the Group's general authority to repurchase ordinary shares. The Share Buyback Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018 and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) and with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures. During any closed periods, the Company and its directors have no power to invoke any changes to the programme, and it will be executed at the sole discretion of Investec and Berenberg, as appropriate.

 

Enquiries:

Hollywood Bowl Group PLC

Via Headland

Stephen Burns, Chief Executive Officer

Antony Smith, Chief Financial Officer

Mat Hart, Group Business Development Director

Headland

hollywoodbowl@headlandconsultancy.com

 

Rosh Field / Antonia Pollock

+44 (0)20 3805 4822

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVERRIIVIR
Date   Source Headline
4th May 20223:02 pmRNSHolding(s) in Company
29th Apr 202211:26 amRNSTotal Voting Rights
28th Apr 20229:16 amRNSHolding(s) in Company
26th Apr 20221:04 pmRNSDirector/PDMR Shareholding
22nd Apr 20223:22 pmRNSHolding(s) in Company
13th Apr 20223:56 pmRNSHolding(s) in Company
8th Apr 20222:49 pmRNSHolding(s) in Company
8th Apr 20227:00 amRNSTrading Statement
6th Apr 202210:57 amRNSHolding(s) in Company
1st Apr 20222:56 pmRNSTotal Voting Rights
1st Apr 202211:22 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSAppointment of Joint Broker
4th Mar 20223:38 pmRNSDirector/PDMR Shareholding
11th Feb 202211:22 amRNSGrant of Options under SAYE Scheme
7th Feb 20222:23 pmRNSBlock listing Interim Review
7th Feb 202210:03 amRNSLTIP Share Awards
4th Feb 20222:45 pmRNSDirector/PDMR Shareholding
31st Jan 202210:54 amRNSTotal Voting Rights
28th Jan 202212:15 pmRNSResult of AGM
21st Jan 202211:59 amRNSHolding(s) in Company
17th Jan 20226:16 pmRNSHolding(s) in Company
17th Jan 202212:40 pmRNSHolding(s) in Company
13th Jan 20223:19 pmRNSHolding(s) in Company
10th Jan 20229:58 amRNSHolding(s) in Company
6th Jan 20223:27 pmRNSDirector/PDMR Shareholding
23rd Dec 202110:07 amRNSAnnual Financial Report and Notice of AGM
15th Dec 20217:00 amRNSFinal Results - Year Ended 30 September 2021
23rd Nov 20213:42 pmRNSHolding(s) in Company
22nd Nov 20219:56 amRNSHolding(s) in Company
10th Nov 20219:57 amRNSHolding(s) in Company
22nd Oct 20211:00 pmRNSNotice of Results
21st Oct 20215:47 pmRNSDirectorate Change
8th Oct 20218:00 amRNSDirector Declaration
8th Oct 20217:00 amRNSTrading Statement - Year Ended 30 September 2021
30th Sep 202110:53 amRNSTotal Voting Rights
31st Aug 202112:47 pmRNSTotal Voting Rights
6th Aug 20217:00 amRNSBlock listing Interim Review
30th Jul 20211:00 pmRNSTotal Voting Rights
27th Jul 20219:17 amRNSDirector/PDMR Shareholding
12th Jul 20211:27 pmRNSDirector/PDMR Shareholding
30th Jun 202112:19 pmRNSTotal Voting Rights
1st Jun 20217:00 amRNSTotal Voting Rights
17th May 20217:00 amRNSHalf-year Results
10th May 20218:56 amRNSNotice of Results
30th Apr 202110:57 amRNSTotal Voting Rights
1st Apr 20213:31 pmRNSTotal Voting Rights
22nd Mar 20219:39 amRNSHolding(s) in Company
12th Mar 20219:30 amRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSResults of Placing
11th Mar 20214:54 pmRNSProposed Placing of New Ordinary Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.